companydata.dkcompanydata.dk

FORWARD PHARMA A/S: Financial statements 2021

CVR: 28865880

Source: annual report 2021, Danish Business Authority

01/01/202131/12/2021

FORWARD PHARMA A/S (CVR 28865880) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -10,812,930 and a net result of DKK -12,271,137 compared with DKK -42,201,691 the year before. Equity in the 2021 report amounted to DKK 461,863,380. The solvency ratio was 82.3%. The company had 2 employees in the financial year.

Gross Profit
DKK -10,812,930
Profit/Loss
DKK -12,271,137
Equity
DKK 461,863,380
Total Assets
DKK 561,060,279
Employees
2

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2021--10.8 mio.-12.3 mio.461.9 mio.2
2020--7.8 mio.-42.2 mio.474.1 mio.2
2019--6 mio.-28.5 mio.515.9 mio.3
20180-7.6 mio.-54.3 mio.534.6 mio.3
20171.3 mia. USD-880.2 mio. USD89.4 mio. USD-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like FORWARD PHARMA A/S

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2021

FORWARD PHARMA A/S: The 2020 annual report is outJun 2, 2021

FORWARD PHARMA A/S has published its annual report for 2020. Gross profit came to DKK -7,763,728, and the net result was DKK -42,201,691.

About FORWARD PHARMA A/S

FORWARD PHARMA A/S was a Danish company of the type Aktieselskab based in Hellerup, founded in 2005. The company has been dissolved on 26 November 2025. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 4 employees (2018). In 2024, the company reported a gross profit of DKK -9,457,909 and a net result of DKK 75,927,645 compared with DKK -3,832,516 the year before. Equity in the 2024 report amounted to DKK 488,330,233.

Source: annual report 2024, Danish Business Authority